The DOI matches its Crossref record; 253 of the 253 references it cites were found in a registry or an index.
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2022
Open accessAbstract
The American Diabetes Association (ADA) “Standards of Medical Care in Diabetes” includes the ADA’s current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee (https://doi.org/10.2337/dc22-SPPC), are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA’s clinical practice recommendations, please refer to the Standards of Care Introduction (https://doi.org/10.2337/dc22-SINT). Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Glycemic management is primarily assessed with the HbA1c test, which was the measure used in trials demonstrating the bene fi ts of glucose lowering (2,52).”
From Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) (2022) · cites this paper as [52]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Autoantibody markers are usually present in 85% to 90% of individuals with type 1 diabetes when fasting hyperglycemia is initially detected (2).”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Chronic diseases, such as T2DM, develop over a long period [102].”
From Digital Health Interventions to Prevent Type 2 Diabetes Mellitus: Systematic Review (2025) · cites this paper as [102]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Overall, 10 of 42 (24%) patients had a 2-hour plasma glucose level ≥140 mg/dL on the oral glucose tolerance test indicative of impaired glucose tolerance according to the World Health Organization (WHO) and the American Diabetes Association.1”
From Pain and small fiber pathology in men with fibromyalgia syndrome (2024) · cites this paper as [1]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“As with any laboratory test, HbA1c measurement has limitations (2,52).”
The cited source says what the claim attributes to it.
In the citing paper
“An HbA 1c value of 6.5% (48 mmol/mol) or greater is considered diagnostic.”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“Depending on the specific MODY mutation, the disease can be mild (e.g., glucokinase mutation) and not usually associated with long term complications of diabetes or as severe as typical type 1 diabetes (e.g., hepatocyte nuclear factor [HNF] mutations) (2).”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“responsive to sulfonylureas”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“genitourinary”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“developmental delay and seizures”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“responsive to sulfonylureas”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“Permanent or transient: IUGR”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“gout”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“IUGR”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“HNF1B | AD”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“Permanent or transient: IUGR”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“HNF1B-MODY”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“atrophy of the pancreas”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“HNF1B-MODY: developmental renal disease”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“KCNJ11 | AD”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“developmental delay”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“ABCC8 | AD”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“insulin requiring”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“IUGR”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“IUGR”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“Permanent: IUGR; insulin requiring”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“hyperuricemia”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“INS | AD”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“medications other than insulin”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“insulin requiring”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“GATA6 | AD”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“EIF2B1 | AD”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“epiphyseal dysplasia”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“mechanisms include UPD6”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“macroglossia”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“EIF2AK3 | AR”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“pancreatic exocrine”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“fluctuating liver function”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“pancreatic hypoplasia”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“Permanent diabetes”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“cardiac”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“pancreatic exocrine”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“Permanent: pancreatic hypoplasia; cardiac”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“immunodysregulation”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“autoimmune diabetes”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“insulin requiring”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“Permanent: Wolcott-Rallison syndrome”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“6q24 (PLAGL1, HYMA1) | AD for paternal duplications”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“IUGR”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“FOXP3 | X-linked”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“Transient: IUGR; macroglossia; umbilical”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“Permanent: immunodysregulation,”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“hernia”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“insulin requiring”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“exfoliative”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“autoimmune thyroid disease”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011 · cited 1×
“The efficacy of interventions for primary prevention of type 2 diabetes (22,23) has mainly been demonstrated among individuals who have impaired glucose tolerance (IGT) with or without elevated fasting glucose, not for individuals with isolated impaired fasting glucose (IFG) or for those with prediabetes defined by A1…”
BackgroundDiagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2010) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 14,094
International Diabetes Federation 2017
Carracher, A. M., Marathe, P. H., & Close, K. L. (2018) · Journal of Diabetes · doi:10.1111/1753-0407.12644 · Cited by 13,379
(2004) · The Lancet · doi:10.1016/s0140-6736(03)15268-3 · Cited by 12,717
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873
IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045
Cho, N. H., Shaw, J. E., Karuranga, S., Huang, Y., da Rocha Fernandes, J. D., Ohlrogge, A. W., & Malanda, B. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.02.023 · Cited by 7,283
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) · Diabetes Care · doi:10.2337/diacare.20.7.1183 · Cited by 6,220
Diagnosis and classification of diabetes mellitus
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s081 · Cited by 5,974
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance.
National Diabetes Data Group (1979) · Diabetes · doi:10.2337/diab.28.12.1039 · Cited by 4,909
Research works printed but not linked: 1
- International Diabetes Federation . IDF Diabetes Atlas, 9th edition. Brussels, Belgium, International Diabetes Federation, 2019. Accessed 15 October 2020. Available from https://www.diabetesatlas.org/en/
Cited by
Sorted by citations
Items 801–900 of 1,009
Mitra, S., Chatterjee, S., Bose, S., Panda, P., Basak, S., Ghosh, N., Mandal, S. C., Singhmura, S., & Halder, A. K. (2023) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2023.108640 · Cited by 16
Zhao, L., & Pan, Q. (2023) · Translational Vision Science & Technology · doi:10.1167/tvst.12.10.17 · Cited by 16
Obesity, diabetes and their metabolic correlates in middle‐aged adults with Down syndrome
Luchsinger, J. A., Pang, D. I., Krinsky‐McHale, S. J., Schupf, N., Lee, J. H., Silverman, W. P., & Zigman, W. B. (2023) · Journal of Intellectual Disability Research · doi:10.1111/jir.13103 · Cited by 16
Júnior, A. S. S., Aidar, F. J., Silva, L. A. S., Silva, T. D. B., de Almeida, S. F. M., Teles, D. C. S., de Lucca, W., Schimieguel, D. M., de Souza, D. A., Nascimento, A. C. S., et al. (2024) · Life · doi:10.3390/life14030336 · Cited by 18
Qiu, Z., Lee, D. H., Lu, Q., Li, R., Zhu, K., Lin, L., Li, R., Pan, A., Giovannucci, E. L., & Liu, G. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae192 · Cited by 16
Standards of Care in Diabetes. The position of Diabetes Poland – 2024
Araszkiewicz, A., Bandurska-Stankiewicz, E. M., Borys, S., Broncel, M., Budzynski, A. Z., Cyganek, K., Cypryk, K., CYRANKA, K. M., Czupryniak, L., Dzida, G. J., et al. (2024) · Current Topics in Diabetes · doi:10.5114/ctd/183052 · Cited by 17
Metabolic disorders in prediabetes: From mechanisms to therapeutic management
Ping, W.-X., Hu, S., Su, J., & Ouyang, S. (2024) · World Journal of Diabetes · doi:10.4239/wjd.v15.i3.361 · Cited by 19
Sun, J., Yang, S., Zhang, Y., Xiang, W., & Jiang, X. (2024) · PLoS ONE · doi:10.1371/journal.pone.0301097 · Cited by 16
Zuliska, S., Maksum, I. P., Einaga, Y., Kadja, G. T. M., & Irkham, I. (2024) · ADMET & DMPK · doi:10.5599/admet.2361 · Cited by 18
Afraie, M., Bahrami, P., Kohnepoushi, P., Khateri, S., Majidi, L., Saed, L., Zamani, K., Mohammadi, H., Moradi, Y., & Moradpour, F. (2024) · Journal of Diabetes Research · doi:10.1155/2024/9960656 · Cited by 24
Peralta, F. G., Romero, L. G. L., Puppo-Moreno, A. M., & Riesgo, J. (2024) · Sensors · doi:10.3390/s24237811 · Cited by 17
Wong, H. J., Lin, N., Teo, Y. H., Yeo, B. S. Y., Toh, K. Z. X., Teo, Y. N., Chan, M. Y., Yeo, L. L. L., Poh, K. K., Kong, W. K. F., et al. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16136 · Cited by 18
Braga, F. O., Negrato, C. A., da Matta, M. D. F. B., Carneiro, J. R. I., & Gomes, M. B. (2019) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000099 · Cited by 18
Gao, S., Liu, Q., Ding, X., Chen, H., Zhao, X.-Q., & Li, H. (2019) · Coronary Artery Disease · doi:10.1097/mca.0000000000000791 · Cited by 16
Barzin, M., Khalaj, A., Tasdighi, E., Nasr, D. S., Mahdavi, M., Banihashem, S., & Valizadeh, M. (2020) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2019.11.002 · Cited by 16
Expression of glucose transporters in duodenal mucosa of patients with type 1 diabetes
Bolla, A. M., Butera, E., Pellegrini, S., Caretto, A., Bonfanti, R., Zuppardo, R. A., Barera, G., Cavestro, G. M., Sordi, V., & Bosi, E. (2020) · Acta Diabetologica · doi:10.1007/s00592-020-01558-w · Cited by 15
Aydın, S., & Fatihoğlu, E. (2020) · Journal of Medical Ultrasound · doi:10.4103/jmu.jmu_29_20 · Cited by 16
de Sá, A. C. M. G. N., Machado, Í. E., Bernal, R. T. I., & Malta, D. C. (2021) · Ciência & Saúde Coletiva · doi:10.1590/1413-81232021262.37102020 · Cited by 16
Shen, Y. H., Zheng, Z., Xiao, L., Liu, C., Guo, J., Chen, Z., Wu, Y., Shi, H., Zhang, Z., Qian, D., et al. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.763021 · Cited by 19
SARS-CoV-2 Seroprevalence in Individuals With Type 1 and Type 2 Diabetes Compared With Controls
Goyal, A., Gupta, Y., Kalaivani, M., Praveen, P. A., Ambekar, S., & Tandon, N. (2021) · Endocrine Practice · doi:10.1016/j.eprac.2021.12.009 · Cited by 16
Yoshimura, M., Fujieda, Y., Sugawara, M., Kono, M., Kato, M., Yokota, I., Amengual, O., Ito, Y. M., & Atsumi, T. (2022) · Rheumatology International · doi:10.1007/s00296-022-05121-4 · Cited by 16
Christinelli, H. C. B., Westphal, G., Costa, M. A. R., Okawa, R. T. P., Nardo, N., & Fernandes, C. A. M. (2022) · Revista Brasileira de Enfermagem · doi:10.1590/0034-7167-2021-0059 · Cited by 16
Rashed Esraa, R., Abhishek, Y., Agrawal, A., Chejara, R. S., & Singh, A. (2020) · International Journal of Diabetes and Clinical Research · doi:10.23937/2377-3634/1410128 · Cited by 16
Ren, Q., Wang, H., Zeng, Y., Tan, X., Cheng, X., Zhou, T., Huang, W. G., & Xu, Y. J. (2023) · Biological Trace Element Research · doi:10.1007/s12011-023-03591-6 · Cited by 16
Association of Patient-Provider Teach-Back Communication with Diabetic Outcomes: A Cohort Study
Hong, Y., Huo, J. S., Jo, A., Cardel, M. I., & Mainous, A. G. (2020) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2020.06.200217 · Cited by 16
Ruste, M., Schweizer, R., Groisne, L., Fellahi, J.-L., & Jacquet-Lagrèze, M. (2024) · British Journal of Anaesthesia · doi:10.1016/j.bja.2023.11.015 · Cited by 15
van Gils, V., Tao, Q., Ang, T. F. A., Young, C. B., Mormino, E. C., Qiu, W. Q., Visser, P. J., Au, R., Jansen, W. J., & Vos, S. J. B. (2024) · Diabetes Care · doi:10.2337/dc24-0162 · Cited by 17
Mansour, A., Rahimi, H. R., Gerami, H., Khorasanian, A. S., Esmaeili, A. H., Bioky, A. A., Mohajeri‐Tehrani, M. R., Fateh, H. R., & Sajjadi‐Jazi, S. M. (2025) · Nutrition Journal · doi:10.1186/s12937-025-01184-8 · Cited by 17
Variation in the classification of hyperglycaemia in pregnancy and its implication
Gupta, Y., Goyal, A., Kalra, S., & Tandon, N. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30018-8 · Cited by 15
Antihyperglycemic and hypoglycemic activity of Mayan plant foods in rodent models
Narváez, J. J. U., Negrete‐León, E., Acevedo‐Fernández, J. J., & Campos, M. R. S. (2021) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.11057 · Cited by 15
Marco, M. D., Urbano, F., Filippello, A., Mauro, S. D., Scamporrino, A., Miano, N., Coppolino, G., L’Episcopo, G., Leggio, S., Scicali, R., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11102870 · Cited by 16
Pregnant women’s experience of undergoing an oral glucose tolerance test: A cross-sectional study
Alecrim, M. D. J., Mattar, R., & Torloni, M. R. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.109941 · Cited by 15
Kupai, K., Várkonyi, T. T., Török, S., Gáti, V., Czimmerer, Z., Puskás, L. G., & Szebeni, G. J. (2022) · Life · doi:10.3390/life12081205 · Cited by 17
Liu, X., Zhang, W., Zhang, Q., Chen, L., Zeng, T., Zhang, J., Min, J., Tian, S., Zhang, H., Huang, H., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1043919 · Cited by 18
Guo, W., Zhu, J., & Liu, W. (2023) · BMC Cardiovascular Disorders · doi:10.1186/s12872-023-03219-6 · Cited by 15
Heath, H., Rosario, R., McMichael, L. E., Fanter, R. K., Alarcon, N., Quintana-Diaz, A., Pilolla, K. D., Schaffner, A. A., Jelalian, E., Wing, R. R., et al. (2023) · Journal of Proteome Research · doi:10.1021/acs.jproteome.2c00430 · Cited by 16
Zhou, H., Jing, J., Pu, Y., Li, W., Meng, X., Wang, A., Zuo, Y., Xu, Z., Xu, Q., Suo, Y., et al. (2023) · Stroke and Vascular Neurology · doi:10.1136/svn-2022-002276 · Cited by 15
Weykamp, C. W., Siebelder, C., Lenters‐Westra, E., Slingerland, R. J., & English, E. (2023) · Clinica Chimica Acta · doi:10.1016/j.cca.2023.117495 · Cited by 16
Greco, M., Mirabelli, M., Salatino, A., Accattato, F., Aiello, V., Brunetti, F. S., CHIEFARI, E. D., Pullano, S. A., Fiorillo, A. S., FOTI, D. P., et al. (2023) · Diagnostics · doi:10.3390/diagnostics13142443 · Cited by 15
Flores, E., Salinas, J. M., Blasco, Á., López‐Garrigós, M., Torreblanca, R., Carbonell, R., Martínez-Racaj, L., & Salinas, M. (2023) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2023.08.006 · Cited by 17
Muhanhali, D., Deng, L., Ai, Z., & Ling, Y. (2023) · Endocrine · doi:10.1007/s12020-023-03508-2 · Cited by 15
Shi, B., Dhaliwal, S. S., soo, M., chan, C., Wong, J., Lam, N. W. C., Zhou, E., Paitimusa, V., Loke, K. Y., Chin, J., et al. (2023) · JMIR AI · doi:10.2196/48340 · Cited by 23
Relationship between cortisol and diabetic microvascular complications: a retrospective study
Sun, S., & Wang, Y. (2023) · European journal of medical research · doi:10.1186/s40001-023-01325-x · Cited by 21
Patel, K. V., Budoff, M. J., Elizondo, J. V., Lahan, S., Ali, S. S., Taha, M. B., Blaha, M. J., Blankstein, R., Shapiro, M. D., Pandey, A., et al. (2023) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.123.015314 · Cited by 15
Cheng, Z., Wang, Y., Jiang, X., Ren, W., Lei, S., Deng, F., & Wu, L. (2023) · Journal of Diabetes Investigation · doi:10.1111/jdi.14090 · Cited by 15
Verapamil chronicles: advances from cardiovascular to pancreatic β-cell protection
Arefanian, H., Koti, L., Sindhu, S. T. A. K., Ahmad, R., Madhoun, A. S. A., & Al‐Mulla, F. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1322148 · Cited by 16
Hua, W., Du, Z., Lu, T., & Tian, L. (2024) · Systematic Reviews · doi:10.1186/s13643-023-02433-9 · Cited by 16
Cavero‐Redondo, I., Saz‐Lara, A., Martínez‐García, I., Otero-Luis, I., & Martínez‐Rodrigo, A. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-023-02104-y · Cited by 17
Zhang, W., Song, W. J., Chen, W., Pan, Z., Zhang, J., Fan, L., & Li, J. (2024) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000002767 · Cited by 18
Damigou, E., Georgoulis, M., Chrysohoou, C. A., Barkas, F., Vlachopoulou, E., Adamidis, P. S., Kravvariti, E., Tsioufis, C. P., Pitsavos, C. E., Liberopoulos, E. N., et al. (2024) · Nutrients · doi:10.3390/nu16081128 · Cited by 17
Mandla, R., Schroeder, P. H., Porneala, B., Florez, J. C., Meigs, J. B., Mercader, J. M., & Leong, A. (2024) · Genome Medicine · doi:10.1186/s13073-024-01337-0 · Cited by 18
Fu, C. E., Teng, M. L. P., Tung, D., Ramadoss, V., Ong, C. E. Y., Koh, B., Lim, W. H., Tan, D. J. H., Koh, J. H., Nah, B. K. Y., et al. (2024) · Digestive Diseases and Sciences · doi:10.1007/s10620-024-08540-4 · Cited by 17
Song, Y., Jiang, L., Han, Y., Zhang, S., & Li, S. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05524-w · Cited by 15
Masserdotti, A., Gasik, M. I., Grillari‐Voglauer, R., Grillari, J., Cargnoni, A., Chiodelli, P., Papait, A., Magatti, M., Romoli, J., Ficai, S., et al. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1411582 · Cited by 15
Mashaba, R. G., Phoswa, W. N., Maimela, E., Lebelo, S. L., Modjadji, P., & Mokgalaboni, K. (2024) · BMJ Open · doi:10.1136/bmjopen-2024-087496 · Cited by 15
Zhao, J., Li, N., Li, S., & Dou, J. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02783-9 · Cited by 15
Glucose metabolism disorders in children with refractory nephrotic syndrome
Takahashi, T., Okamoto, T., Sato, Y., Hayashi, A., Ueda, Y., & Ariga, T. (2020) · Pediatric Nephrology · doi:10.1007/s00467-019-04360-1 · Cited by 15
Ruiz-Martínez, M. L., Gómez-Díaz, R. A., González, A. L. V., González, R. M., Sánchez-Becerra, M. C., Rio, S. L. G. D., Cruz, M., Wacher, N. H., Pacheco, R. A. R., & Aburto, V. H. B. (2020) · Nutrition · doi:10.1016/j.nut.2020.110901 · Cited by 17
Hammer, M. J., Eckardt, P. A., Cartwright, F., & Miaskowski, C. A. (2020) · Nursing Research · doi:10.1097/nnr.0000000000000468 · Cited by 16
Reddy, A., Halenda, K. M., Cromer, P., Chen, L., Butler, J., Raed, A., Bhagatwala, J., Sponseller, T., Bollinger, K. E., Zhu, H., et al. (2020) · Journal of Glaucoma · doi:10.1097/ijg.0000000000001673 · Cited by 16
IMPACT OF DIABETIC NEUROPATHY ON QUALITY OF LIFE AND POSTURAL BALANCE IN BRAZILIAN OLDER ADULTS
Ernandes, R. D. C., Brech, G. C., Luna, N. M. S., Bega, A., GUIMARÃES, D. S., Bocalini, D. S., Júnior, G. S., Greve, J. M. D., Leme, L. E. G., & Alonso, A. C. (2020) · Acta Ortopédica Brasileira · doi:10.1590/1413-785220202806234529 · Cited by 15
Management of Women with Polycystic Ovary Syndrome During Pregnancy
Valent, A. M., & Barbour, L. A. (2021) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2020.10.005 · Cited by 17
Paurobally, N., Kruger, E., & Tennant, M. (2021) · International Dental Journal · doi:10.1016/j.identj.2020.12.019 · Cited by 18
Disturbed Interhemispheric Functional and Structural Connectivity in Type 2 Diabetes
Cui, Y., Tang, T., Lu, C., Lu, T., Wang, Y., Teng, G., & Ju, S. (2021) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.27813 · Cited by 15
Diabetes Prevention in a U.S. Healthcare System: A Portrait of Missed Opportunities
Mainous, A. G., Rooks, B. J., Wright, R. U., Sumfest, J. M., & Carek, P. J. (2021) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2021.06.018 · Cited by 16
Maia, M. B., Souza, J. G. S., Bertolini, M., Costa, R. C., Costa, G. S., Torres, S. D. A. S., Ferreira, E. F. E., & Martins, A. M. E. B. L. (2022) · International Journal of Dental Hygiene · doi:10.1111/idh.12586 · Cited by 15
A Cluster Randomized Noninferiority Field Trial of Gestational Diabetes Mellitus Screening
Ramezani Tehrani, F., Behboudi-Gandevani, S., Farzadfar, F., Hosseinpanah, F., Hadaegh, F., Khalili, D., Soleymani-Dodaran, M., Valizadeh, M., Abedini, M., Rahmati, M., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac181 · Cited by 15
Maternal and Fetal Metabolites in Gestational Diabetes Mellitus: A Narrative Review
Vladu, I. M., Clenciu, D., Mitrea, A., Amzolini, A. M., Micu, S. E., Crișan, A. E., Efrem, I. C., Forţofoiu, M., Forţofoiu, M., Mită, A., et al. (2022) · Metabolites · doi:10.3390/metabo12050383 · Cited by 17
Wang, S., Gu, L., Chen, J. C., Jiang, Q., Sun, J., Wang, H., & Wang, L. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.109990 · Cited by 15
Xiu, W., Huang, Y., Li, Y., Yu, M., & Gong, Y. (2021) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000001133 · Cited by 15
Gupta, K., Kakar, T. S., Jain, V., Gupta, M., Rifai, M. A., Slipczuk, L. N., Nambi, V., Bittner, V., Blumenthal, R. S., Stone, N. J., et al. (2022) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2022.08.007 · Cited by 15
Takahashi, Y., Biller, B. M. K., Fukuoka, H., Ho, K. K. Y., Rasmussen, M. H., Nedjatian, N., Sværke, C., Yuen, K. C. J., & Johannsson, G. (2022) · Pituitary · doi:10.1007/s11102-022-01283-3 · Cited by 15
Song, Y., Chang, Z., Cui, K., Song, C., Cai, Z., Shi, B., Dong, Q., & Dou, K. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1129667 · Cited by 15
Kanimozhi, N., & Singaravel, G. (2021) · Medical & Biological Engineering & Computing · doi:10.1007/s11517-021-02333-x · Cited by 15
Self-care among people with Diabetes Mellitus and quality of care in Primary Health Care
Suplici, S. E. R., Meirelles, B. H. S., de Lacerda, J. T., & da Silva, D. M. G. V. (2021) · Revista Brasileira de Enfermagem · doi:10.1590/0034-7167-2020-0351 · Cited by 15
Digital Health Interventions to Prevent Type 2 Diabetes Mellitus: Systematic Review
Duong, T., Olsen, Q., Menon, A., Woods, L., Wang, W., Varnfield, M., Jiang, L., & Sullivan, C. (2025) · Journal of Medical Internet Research · doi:10.2196/67507 · Cited by 14
Wang, L., Steele, E. M., Du, M., Luo, H., Zhang, X., Mozaffarian, D., & Zhang, F. F. (2025) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2024.11.014 · Cited by 16
Impact of Serum Glucose Levels on Outcomes in Acute Pancreatitis: A Retrospective Analysis
Balaban, M., Balaban, D. V., Enache, I., Nedelcu, I. C., Jinga, M., & Gheorghe, C. (2024) · Medicina · doi:10.3390/medicina60060856 · Cited by 14
Cluster Analysis in Diabetes Research: A Systematic Review Enhanced by a Cross-Sectional Study
Taurbekova, B., Sarsenov, R., Yaqoob, M. M., Atageldiyeva, K. K., Semenova, Y. M., Fazli, S., Starodubov, A., Angalieva, A., & Sarría‐Santamera, A. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14103588 · Cited by 18
Liu, Y., Wen, H., Bai, J., Shi, F., Bi, R., & Yu, C. (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.156495 · Cited by 14
Pulmonary Tuberculosis-Related Ischemic Stroke: A Retrospective Case Control Study
Wei, Y., Tang, S., Xie, Z., He, Y., Zhang, Y., Xie, Y., Chen, S., Liu, L., Liu, Y., & Liang, Z. (2022) · Journal of Inflammation Research · doi:10.2147/jir.s368183 · Cited by 14
Nicolaisen, S. K., Thomsen, R. W., Lau, C. J., Sørensen, H. T., & Pedersen, L. H. (2022) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2022-002946 · Cited by 14
Han, E., Kim, M. K., Lee, H. W., Ryu, S. W., Kim, H. S., Jang, B. K., & Suh, Y. S. (2022) · Obesity · doi:10.1002/oby.23576 · Cited by 13
Tripolt, N. J., Hofer, S. J., Pferschy, P. N., Aziz, F., Durand, S., Aprahamian, F., Nirmalathasan, N., Waltenstorfer, M., Eisenberg, T., Obermayer, A. M., et al. (2023) · Nutrients · doi:10.3390/nu15030511 · Cited by 16
mTORC1 syndrome (TorS): unified paradigm for diabetes/metabolic syndrome
Bar‐Tana, J. (2023) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2023.01.001 · Cited by 16
Hypomagnesemia and Poor Glycemic Control among Type 2 Diabetic Patients: A Cross-Sectional Study
Hamarshih, M., Hamshari, S., Nazzal, Z. A. S., Snobar, F. A., Mletat, R., Abu-Mazen, O., & Maraqa, B. N. (2022) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_213_22 · Cited by 14
Association of metformin, aspirin, and cancer incidence with mortality risk in adults with diabetes
Orchard, S. G., Lockery, J. E., Broder, J. C., Ernst, M. E., Espinoza, S. E., Gibbs, P., Wolfe, R. S., Polekhina, G., Zoungas, S., Loomans-Kropp, H. A., et al. (2023) · JNCI Cancer Spectrum · doi:10.1093/jncics/pkad017 · Cited by 15
Portes, J., Bullón, B., Gallardo, I., Riejos, P. F., Quiles, J. L., Giampieri, F., & Bullón, P. (2023) · Journal of Dentistry · doi:10.1016/j.jdent.2023.104480 · Cited by 14
Cabrini, M. L., Macedo, T. A., Castro, E. F. D. S. E., de Barros, S., Azam, I. F. B., Pio-Abreu, A., da Silva, G. V., Lorenzi‐Filho, G., Bortolotto, L. A., & Drager, L. F. (2023) · Hypertension Research · doi:10.1038/s41440-023-01320-z · Cited by 17
Júnior, F. P., Santos, Â. B. S., Englert, E. F., Mazzutti, G., Costa, G. O. M., Saffi, M. A. L., Liedke, P. E. R., Fritsch, V. H., & Biolo, A. (2023) · Breast Cancer Research and Treatment · doi:10.1007/s10549-023-06979-z · Cited by 14
Martino, F., Bassareo, P. P., Martino, E., Romeo, F., Calcaterra, G., Filardi, P. P., Indolfi, C., Nodari, S., Montemurro, V., Guccione, P., et al. (2023) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000001488 · Cited by 15
Correlation between symptoms of depression, attitude, and self-care in elderly with type 2 diabetes
Frazão, M. C. L. O., Viana, L. R. D. C., Ferreira, G. R. S., Pimenta, C. J. L., da Silva, C. R. R., Madruga, K. M. D. A., Batista, P. S. D. S., & Costa, K. N. D. F. M. (2023) · Revista Brasileira de Enfermagem · doi:10.1590/0034-7167-2022-0741 · Cited by 14
Intramyocellular Triglyceride Content During the Early Course of Type 1 and Type 2 Diabetes
Schön, M., Zaharia, O., Straßburger, K., Kupriyanova, Y., Bódis, K. B., Heilmann, G., Strom, A., Bönhof, G. J., MICHELOTTI, F. C., Yurchenko, I., et al. (2023) · Diabetes · doi:10.2337/db23-0353 · Cited by 14
Lai, Z., Liu, Y., Huang, M., Li, L., Li, Z., Su, J., Pan, G., Li, B., Gao, S., & Yu, C. (2023) · Heart Lung and Circulation · doi:10.1016/j.hlc.2023.05.012 · Cited by 14
Renewing the fight: A call to action for diabetes and chronic kidney disease
Pecoits‐Filho, R., Jiménez, B. Y., Ashuntantang, G., de Giorgi, F., Cosmo, S. D., Groop, P., Liew, A., Hradsky, A., Pontremoli, R., Solá, L., et al. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110902 · Cited by 14
Prediabetes is an incremental risk factor for adverse cardiac events: A nationwide analysis
Nanavaty, D., Green, R., Sanghvi, A., Sinha, R., Singh, S., Mishra, T., Devarakonda, P. K., Bell, K., Ayala-Rodriguez, C. E., Gambhir, K. K., et al. (2023) · Atherosclerosis Plus · doi:10.1016/j.athplu.2023.08.002 · Cited by 17
Slurink, I. A. L., Corpeleijn, E., Bakker, S. J. L., Jongerling, J., Kupper, N. H. M., Smeets, T., & Soedamah‐Muthu, S. S. (2023) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2023.10.002 · Cited by 14
Mazzù, M. F., Baccelloni, A., & Romani, S. (2023) · British Food Journal · doi:10.1108/bfj-04-2023-0285 · Cited by 14
Research Progress on the Relationship between Vitamins and Diabetes: Systematic Review
Liu, J., Qin, L., Zheng, J., Tong, L., Lu, W., Lu, C., Sun, J., Fan, B., & Wang, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216371 · Cited by 18
Proteomic analysis of aqueous humor reveals novel regulators of diabetic macular edema
Zhang, Y., Xu, M., He, H., Ren, S., Chen, X., Zhang, Y., An, J., Ren, X., Zhang, X., Zhang, M., et al. (2023) · Experimental Eye Research · doi:10.1016/j.exer.2023.109724 · Cited by 14
Metadata
- Authors
- American Diabetes Association Professional Practice Committee
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2021-12-16
- Volume
- 45
- Issue
- Supplement_1
- Pages
- S17-S38
- ISSN
- 0149-5992 (ISSN-L)
- OpenAlex
- W4200148796
- Semantic Scholar
- a1d863e5f4d381bf99eea7ee26e18dcc69f81a15
- Cited by
- 4,792
- References
- 253
- Citations by year
- 2026: 293 · 2025: 689 · 2024: 1026 · 2023: 1164 · 2022: 814 · 2021: 356
- FWCI
- 129.37
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- diabetes classification, diabetes diagnosis, diabetes diagnosis criteria, diabetes subtypes
- MeSH terms
- Diabetes Mellitus, Endocrinology, Humans, Reference Standards, Societies, Medical, Standard of Care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
